The official logo of Nigh Goldenberg Raso & Vaughn, PLLC, featuring the law firm's name in stylized typography with a professional color scheme.

Ozempic Lawsuit

Ozempic is a Popular Drug with a Hidden Danger: Gastroparesis

Ozempic  recently emerged as a beacon in the diabetic pharmaceutical industry, promising not merely blood sugar regulation but also weight loss for those grappling with type 2 diabetes.

The widespread popularity of this drug, however, has recently been shadowed by increasing reports of severe side effects and a crescendo of legal issues, resulting in lawsuits against Ozempic’s manufacturers.

With Nigh Goldenberg Raso & Vaughn at the forefront of advocating for justice for those injured by harmful medications, we have decided to continue this work with Ozempic patients, specifically those with gastroparesis.

A Brief Overview of Ozempic

Ozempic, also known by its generic name Semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist. This type of medication is designed to increase insulin secretion, slow glucose absorption, and reduce the amount of glucose produced by the liver. In doing so, it aims to control blood sugar levels in patients with type 2 diabetes.

While the primary purpose of Ozempic is to manage diabetes, it has also been promoted for weight loss. This is largely due to the drug’s ability to slow the emptying of the stomach, leading to a feeling of fullness and reduced food intake. However, this slowed gastric emptying can also lead to severe gastrointestinal issues, the most concerning of which is gastroparesis, or stomach paralysis.

Close-up of Ozempic injector with blurred Ozempic packaging in the background, represented by Nigh Goldenberg Raso & Vaughn law firm in ongoing lawsuit

The Dangers of Gastroparesis

Gastroparesis is a condition in which the stomach cannot empty food properly. It is characterized by symptoms such as nausea, vomiting, abdominal bloating, and pain. In severe cases, it can lead to malnutrition and weight loss.

The link between Ozempic and gastroparesis came into the spotlight following numerous reports from patients who experienced severe vomiting of undigested, sometimes days’ old food. Endoscopic examinations revealed that these patients often had a stomach full of food, indicating delayed gastric emptying. In some cases, patients required surgery to relieve their symptoms.

The onset of symptoms following the use of Ozempic has led scientists to believe that the drug could be a contributing factor. This has sparked an ongoing investigation into the safety of Ozempic and other GLP-1 agonists.

Asserting Your Rights: Nigh Goldenberg Raso & Vaughn Advocates for Victims of Harmful Medication Side Effects

The dedicated attorneys at Nigh Goldenberg Raso & Vaughn are extending their expertise advocating for those injured by harmful medications to those suffering due to the use of drugs like Ozempic. With a specialized focus on cases that involve harmful medications, the firm is currently accepting cases involving:

  • Gastroparesis: A condition where the stomach cannot empty food properly, leading to nausea, vomiting, and severe abdominal bleeding.
  • Intestinal Obstruction (Ileus): A potentially life-threatening condition where the intestine is blocked, inhibiting the passage of foods and fluids.

The team at Nigh Goldenberg Raso & Vaughn is diligently working to secure justice for those who have suffered from medical complications related to their Ozempic use. If you or a loved one has experienced any of the above-mentioned complications, please contact us today.

Ozempic Compensation Claims

The rising concern over the possible link between Ozempic and gastroparesis and ileus has led to a surge in Ozempic lawsuits. The plaintiffs allege that Novo Nordisk, the manufacturer of Ozempic, failed to adequately warn patients and doctors about the potential risks.

The first of these lawsuits was filed in August 2023 by a 44-year-old woman from Louisiana. She alleged that she developed severe gastroparesis after taking Ozempic, leading to multiple hospitalizations, extreme vomiting, and significant abdominal pain. The lawsuit further alleges that the Defendants did not include warnings of gastroparesis in the prescription label, thereby failing to fulfill its duty to consumers.

The filing of this lawsuit marked the beginning of the legal battle against the manufacturers of Ozempic. We expect many more claims to follow. At the heart of these lawsuits is the claim that Novo Nordisk prioritized profits over patient safety which ultimately led to undue suffering for those who suffered after using Ozempic.

The Role of Ozempic Attorneys in Protecting Ozempic Users

As the number of Ozempic lawsuits around the country continues to grow, the role of attorneys participating in these claims becomes increasingly critical. Nigh Goldenberg Raso and Vaughn is dedicated to holding pharmaceutical companies accountable for their actions and fights tirelessly to ensure patients are adequately compensated for their injuries.

In these cases, we are tasked with gathering evidence, building strong cases, and advocating for our clients in the court system. We also work closely with medical experts to understand the link between Ozempic and gastroparesis.

Man holding an Ozempic injector showcasing diabetes management, related to Nigh Goldenberg Raso & Vaughn's legal advocacy

The Future of Ozempic Lawsuits: What to Expect

The future of the Ozempic litigation remains uncertain as the claims against Novo Nordisk are still in the early stages. However, given the severity of the reported side effects and the number of patients impacted, it is likely that the litigation will continue to grow.

As more evidence comes to light, it is possible that additional side effects and injuries may be linked to Ozempic use, leading to an even larger litigation.

In the meantime, patients who have suffered from gastroparesis or other severe side effects after taking Ozempic are encouraged to seek legal advice as soon as possible. By taking action, they can help hold the Defendants accountable, while also securing the compensation they are rightfully entitled to.

Conclusion

The emergence of the Ozempic lawsuit underscores the importance of patient safety and corporate responsibility in the pharmaceutical industry. While medications like Ozempic can offer significant health benefits for those struggling with Type II Diabetes, they must be used with caution due to the potential for severe side effects.

Patients who have experienced gastroparesis or other serious injuries after taking Ozempic have the right to seek compensation for their injuries.

If you or a loved one has suffered from these injuries, we encourage you to contact us for a free consultation. Our skilled team is ready to listen to your story, evaluate your case, and discuss the best course of action moving forward. Remember, you are not alone in this fight, and with our help, we can seek justice together.

Additional Resources

If you’re looking to explore this issue further, here are some resources that might be of interest:

If you are interested in pursuing a claim today, contact Nigh Goldenberg Raso & Vaughn. There are no upfront fees. Call us at (202) 792-2927 or fill out the form below for a free consultation.

Quick Links

Looking for help?

Contact Us Now!

Active Cases

Active Cases

Free Consultation

Fill out the form below or call Nigh Goldenberg Raso & Vaughn today for a free consultation 202-792-7927

Skip to content